Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)

Clinical trial NCT00258778 · COMPLETED

Trial details

NCT number: NCT00258778
Sponsor: Protalix
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gaucher Disease

Start date: 2005-11-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.